Alpha Tau Medical (DRTS) Retained Earnings (2020 - 2026)
Alpha Tau Medical's (DRTS) quarterly Retained Earnings came in at -$213.1 million in Q1 2026, down 36.41% year-on-year from -$335.1 million in Q1 2025, and down 12.06% quarter-over-quarter from -$190.1 million in Q4 2025.
Alpha Tau Medical (DRTS) Retained Earnings (2020 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Retained Earnings across 7 years of filings, most recently posting -$213.1 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$213.1 million, down 36.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$213.1 million (down 36.41% YoY), and the FY2025 annual result was -$190.1 million, down 28.9% from the prior year.
- Retained Earnings came in at -$213.1 million for Q1 2026 at Alpha Tau Medical, down from -$190.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$78.6 million in Q1 2022 to a low of -$213.1 million in Q1 2026.
- The 5-year median for Retained Earnings is -$123.7 million (2024), against an average of -$129.1 million.
- Across the five-year window, Retained Earnings sank 63.89% in 2022 and fell 20.62% in 2023, its largest moves.
- Alpha Tau Medical's Retained Earnings stood at -$86.6 million in 2022, then tumbled by 33.67% to -$115.8 million in 2023, then declined by 27.43% to -$147.5 million in 2024, then retreated by 28.9% to -$190.1 million in 2025, then slipped by 12.06% to -$213.1 million in 2026.
- The last three Retained Earnings figures came in at -$213.1 million (Q1 2026), -$190.1 million (Q4 2025), and -$178.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | -213.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -213.08 Mn |
| Dec 31, 2025 | -190.14 Mn |
| Sep 30, 2025 | -178.00 Mn |
| Jun 30, 2025 | -166.31 Mn |
| Mar 31, 2025 | -156.20 Mn |
| Dec 31, 2024 | -147.51 Mn |
| Sep 30, 2024 | -138.03 Mn |
| Jun 30, 2024 | -131.11 Mn |
| Mar 31, 2024 | -123.74 Mn |
| Dec 31, 2023 | -115.76 Mn |
| Sep 30, 2023 | -108.39 Mn |
| Jun 30, 2023 | -103.48 Mn |
| Mar 31, 2023 | -94.79 Mn |
| Dec 31, 2022 | -86.60 Mn |
| Sep 30, 2022 | -83.21 Mn |
| Jun 30, 2022 | -80.58 Mn |
| Mar 31, 2022 | -78.58 Mn |
| Dec 31, 2021 | -52.84 Mn |
| Dec 31, 2020 | -25.57 Mn |